Read + Share
Goyal RK, Holmes HM, Chen H, Abughosh S, et al. Impact of CDK4/6 inhibitors on chemotherapy utilization in earlier therapy lines
for HR+/HER2- metastatic breast cancer in the United States. Breast Cancer Res Treat 2023 Jan 7. doi: 10.1007/s10549-022-06845.
PMID: 36609900
|
 |
|
